Buccafusco, Jerry J.

The Cholinergic Hypothesis of Age and Alzheimer’s Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development

Terry, A. V., & Buccafusco, J. J. (2003) · The Journal of Pharmacology and Experimental Therapeutics

Alzheimer's disease research and treatmentsCholinesterase and Neurodegenerative Diseases

Cited by 1,159

Guidelines on nicotine dose selection for in vivo research

Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology

Smoking Behavior and CessationNicotinic Acetylcholine Receptors Study

Cited by 824

Desensitization of nicotinic acetylcholine receptors as a strategy for drug development

Buccafusco, J. J., Beach, J. W., & Terry, A. V. (2009) · The Journal of Pharmacology and Experimental Therapeutics

Nicotinic Acetylcholine Receptors StudyNeuroscience and Neuropharmacology Research

Cited by 144

In Vivo Pharmacological Characterization of a Novel Selective α7 Neuronal Nicotinic Acetylcholine Receptor Agonist ABT-107: Preclinical Considerations in Alzheimer's Disease

Bitner, R. S., Bunnelle, W. H., Decker, M. W., Drescher, K. U., Kohlhaas, K. L., Markosyan, S., Marsh, K. C., Nikkel, A. L., Browman, K., Radek, R., et al. (2010) · The Journal of Pharmacology and Experimental Therapeutics

Nicotinic Acetylcholine Receptors StudyAlzheimer's disease research and treatments

Cited by 97

ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys

Decker, M. W., Bannon, A. W., Curzon, P., Gunther, K. L., Brioni, J. D., Holladay, M. W., Lin, N.-H., Li, Y., Daanen, J. F., Buccafusco, J. J., et al. (1997) · The Journal of Pharmacology and Experimental Therapeutics

Nicotinic Acetylcholine Receptors StudyCholinesterase and Neurodegenerative Diseases

Cited by 88

Central Anticholinergic Hypersensitivity in Aging

Ray, P. G., Meador, K. J., Loring, D. W., Zamrini, E. W., Yang, X.-H., & Buccafusco, J. J. (1992) · Journal of Geriatric Psychiatry and Neurology

Cholinesterase and Neurodegenerative DiseasesDementia and Cognitive Impairment Research

Cited by 75

Structure−Activity Studies on 2-Methyl-3-(2(S)-pyrrolidinylmethoxy)pyridine (ABT-089): An Orally Bioavailable 3-Pyridyl Ether Nicotinic Acetylcholine Receptor Ligand with Cognition-Enhancing Properties

Lin, N.-H., Gunn, D. E., Ryther, K. B., Garvey, D. S., Donnelly-Roberts, D. L., Decker, M. W., Brioni, J. D., Buckley, M. J., Rodrigues, A. D., Marsh, K. G., et al. (1997) · Journal of Medicinal Chemistry

Nicotinic Acetylcholine Receptors StudyCholinesterase and Neurodegenerative Diseases

Cited by 67